PET/MR在肿瘤中的临床应用:最新进展
本文综述PET/MRI在肿瘤中的应用进展。PET/MRI因成本高及需验证其相对PET/CT的增量获益而普及较慢,早期仅用MRI做解剖定位;近期研究转向多参数潜力,采用扩散加权和其他功能序列,结合局部原发分期与全身一站式分期,并引入影像组学分析,在多种肿瘤中显示价值。
要点
- PET/MRI普及较慢,部分因系统成本高且需验证相对PET/CT或序贯PET/CT与MRI的增量获益。
- 早期MRI部分主要用于解剖成像,仅用于解剖定位会削弱PET/MRI的潜力。
- 近期研究聚焦多参数潜力,采用扩散加权等功能序列及影像组学分析,在多种肿瘤中显示价值。
核心结论
- PET/MRI的多参数整合及影像组学分析在多种肿瘤中显示有价值,可用于基于多参数成像的局部原发分期及全身一站式分期。
研究设计与样本
- 本文为综述,讨论PET/MRI在肿瘤中的临床应用进展,未报告系统检索范围。
主要发现
- PET/MRI普及率较慢,部分原因是系统成本高及需验证相对PET/CT或序贯PET/CT与MRI的增量获益。
- 早期PET/MRI的MRI部分主要用于解剖成像,仅用于解剖定位会削弱其潜力。
- 近期研究聚焦多参数潜力,采用扩散加权序列和其他功能成像序列。
- 多参数成像用于局部原发分期并包含全身一站式分期,结合影像组学分析,在多种肿瘤中显示有价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The combination of PET and MRI is one of the recent advances of hybrid imaging. Yet to date, the adoption rate of PET/MRI systems has been rather slow. This seems to be partially caused by the high costs of PET/MRI systems and the need to verify an incremental benefit over PET/CT or sequential PET/CT and MRI. In analogy to PET/CT, the MRI part of PET/MRI was primarily used for anatomical imaging. Though this can be advantageous, for example in diseases where the superior soft tissue contrast of MRI is highly appreciated, the sole use of MRI for anatomical orientation lessens the potential of PET/MRI. Consequently, more recent studies focused on its multiparametric potential and employed diffusion weighted sequences and other functional imaging sequences in PET/MRI. This integration puts the focus on a more wholesome approach to PET/MR imaging, in terms of releasing its full potential for local primary staging based on multiparametric imaging and an included one-stop shop approach for whole-body staging. This approach as well as the implementation of computational analysis, in terms of radiomics analysis, has been shown valuable in several oncological diseases, as will be discussed in this review article.
引用
- Seifert R, Kersting D, Rischpler C, et al. Clinical Use of PET/MR in Oncology: An Update. Semin Nucl Med. 2021. PMID: 34980479. doi:10.1053/j.semnuclmed.2021.11.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。